FCM
EVH icon

Farallon Capital Management’s Evolent Health EVH Stock Holding History

Farallon Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.9K Hold
14,000
– – ﹤0.01% 169
2025
Q4 		$56K Hold
14,000
– – ﹤0.01% 148
2025
Q3 		$118K Hold
14,000
– – ﹤0.01% 134
2025
Q2 		$158K Hold
14,000
– – ﹤0.01% 126
2025
Q1 		$133K Hold
14,000
– – ﹤0.01% 130
2024
Q4 		$158K Sell
14,000
-625,000
-98% -$11M ﹤0.01% 134
2024
Q3 		$18.1M Buy
+639,000
New +$16.5M 0.08% 77
2024
Q2 		– Sell
-1,037,331
Closed -$34M – 175
2024
Q1 		$34M Sell
1,037,331
-1,126,578
-52% -$36M 0.14% 62
2023
Q4 		$71.5M Buy
2,163,909
+263,000
+14% +$7.44M 0.33% 53
2023
Q3 		$51.8M Hold
1,900,909
– – 0.24% 57
2023
Q2 		$57.6M Buy
1,900,909
+757,000
+66% +$24.5M 0.29% 65
2023
Q1 		$37.1M Buy
1,143,909
+841,909
+279% +$26.6M 0.2% 67
2022
Q4 		$8.48M Buy
+302,000
New +$8.66M 0.05% 114

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Farallon Capital Management's EVH Position: Q1 2026 in Review

Farallon Capital Management held its Evolent Health (EVH) position steady in Q1 2026 at 14,000 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

Farallon Capital Management first reported a position in EVH in Q4 2022 and has held it in 13 quarters since. The position peaked at $71.5M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Farallon Capital Management held 14,000 shares of Evolent Health worth $31.9K as of Q1 2026.
  • Farallon Capital Management left its Evolent Health share count unchanged in Q1 2026.
  • Evolent Health made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #169 holding.
  • Farallon Capital Management first reported a position in Evolent Health in Q4 2022 and has held it in 13 quarters since.
  • Farallon Capital Management's Evolent Health position peaked at $71.5M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.